Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis Pigmentosa
Status:
Not yet recruiting
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and efficacy of a single
escalating doses of ZVS203e administered via subretinal injection in participants with RP
caused by RHO site-specific gene mutation (RHO-RP).